We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Innovative Bone Graft Delivery System for Orthopedic Surgery

By HospiMedica International staff writers
Posted on 21 Oct 2010
A novel preloaded syringe improves upon conventional delivery methods of bone graft substitutes during orthopedic surgeries.

The NovaBone Putty MIS Delivery System is designed for use in minimally invasive orthopedic procedures. More...
The system is composed of a syringe preloaded with ready-to-use NovaBone Putty, and 6-mm diameter cannulae at varying lengths. The system works by delivering an osteoconductive matrix while signaling and stimulating osteoblastic activity to the orthopedic surgical site. The NovaBone Putty MIS Delivery System is a product of Novabone (Jacksonville, FL, USA; novabone.com), and has been approved by the U.S. Food and Drug Administration (FDA) for use in orthopedic surgeries of the extremities, the pelvis, and posterolateral spine.

NovaBone Putty is a versatile bone graft substitute that is ready to use out of the package with exceptional handling characteristics. The specially formulated consistency means it can be packed into any size or shape void, without sticking to surgical gloves. The binder resists migration during irrigation, allowing the bioactive component to stay as placed.

"The launch of the MIS Delivery System will be just the beginning of products our company will be offering to spine surgeon, neurosurgeons, and orthopedic surgeons,” said Art Wotiz, President of NovaBone Products. "As a growing medical device company, we will introduce a number of new products this year and through 2011 that are based on advancements in bioengineered medical technology.”

Related Links:

NovaBone



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.